Zobrazeno 1 - 10
of 45
pro vyhledávání: '"35"'
Autor:
Loukianos S. Rallidis, Dimitrios Th. Kremastinos, Ioannis Lekakis, Christoforos Komporozos, Argiro Gialeraki, Anthi Travlou, Panagiotis Vavoulis, Georgios P Pavlakis
Publikováno v:
Atherosclerosis. 200:115-120
The pathogenetic mechanism of premature myocardial infarction (MI) remains unknown. We explored the association of homocysteine and its main genetic modulator methylenetetrahydrofolate reductase (MTHFR) 677C-T polymorphism with the development of MIo
Autor:
Kristine Lindhard, Lars Bo Nielsen, Bo Feldt-Rasmussen, Marianne Bertelsen, Susanne Bro, Ellen Freese, Christina Christoffersen, Henrik Ullum, Ida Mh. Sørensen
Publikováno v:
Atherosclerosis. 275:304-311
Plasma apolipoprotein M (APOM) is bound to HDL-particles and has anti-atherogenic effects. The present study explored whether plasma APOM is reduced in patients with chronic kidney disease (CKD), and associated with cardiovascular disease (CVD). In a
Autor:
Michelle Xueqin Lin, Su Chi Lim, Subramaniam Tavintharan, Hean Yee Ong, Jessie Choi Wan Fong, Justin I-Shing Tang, Sharon Li Ting Pek, Chee Fang Sum, Chee Wan Lee, Eric Zit Liang Chan, Sanjaya Dissanayake
Publikováno v:
Atherosclerosis. 269:106-116
Background and aims Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease characterized by the presence of high plasma low density lipoproteins cholesterol (LDL-c). Patients with FH, with mutation detected, are at increased risk
Autor:
Shuang Shao, Shiyun Qin, Shan Huang, Rong-jie Huang, Baojing Lin, Shuo Li, Tangwei Liu, Jiang-nan Huang, Zhi-yuan Jiang
Publikováno v:
Atherosclerosis. 268:19-26
Increased volume of visceral adipose tissue is associated with worsening of cardiovascular disease risk factors that contribute to aortic dilatation. We investigated the effects of visceral fat index (VFI) and VFI/percentage body fat (PBF) ratio on p
Publikováno v:
Atherosclerosis. 263:249-256
Background and aims We identified distinct patterns of metabolic risk factors (MRF), and examined their association with subsequent cardiovascular disease (CVD) risk. Methods The study sample included 8113 participants (45% men) aged ≥30 years. Sel
Autor:
Sungha Park, Sang Hak Lee, Sul A Lee, Dong Ryeol Ryu, Young Eun Kwon, Han Jak Ryu, Seung Hyeok Han, Shin Wook Kang, Mi Jung Lee, Yung Ly Kim, Jung Tak Park, Hyung Jung Oh, Bo Young Nam, Tae Hyun Yoo, Kyoung Sook Park
Publikováno v:
Atherosclerosis. 242:476-482
In end-stage renal disease, deleterious effect of sarcopenia on cardiovascular disease has been explained mainly by chronic inflammation. However, evidence emerged that skeletal muscles mediate their protective effect against sarcopenia by secreting
Publikováno v:
Atherosclerosis. 71:9-16
Retrospective analysis of ulcer healing trials utilizing enprostil, a synthetic dehydroprostaglandin E2 analogue, has demonstrated a 10% or greater reduction in total serum cholesterol in 64%, 64% and 67%, respectively, of hypercholesterolemic subjec
Publikováno v:
Atherosclerosis. 13:247-254
In human aortae with sclerotic changes 35 SO 4 2− —incorporation rates into aMPS were compared in normal parts and parts with sclerotic lesions. In sclerotic lesions the concentrations of aMPS, chondroitin-6 and/or -4-sulfate and heparan sulfate
Autor:
Joel Estis, Stéphanie van der Lely, John A. Todd, Tobias Schoen, Martin Risch, Lorenz Risch, Stefanie Aeschbacher, David Conen, Matthias Bossard, Tschuenschen Lam, Katrin Pumpol, Philipp Krisai
Publikováno v:
Atherosclerosis
OBJECTIVES Endothelial dysfunction is a major precursor of atherosclerosis. The aim of this study was to assess the interrelationships between plasma endothelin 1 (ET 1) levels and cardiovascular risk among young and healthy individuals. METHODS We p
Publikováno v:
Atherosclerosis. 235:110-115
This study was designed to retrospectively investigate whether percutaneous transluminal angioplasty (PTA) is efficacious and safe for the treatment of atypical thromboangiitis obliterans (ATAO) in arteries with occlusion of long segments.From Januar